UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 86

Sortiert nach

Research on molecular mechanisms of McArdle's disease (muscle glycogen phosphorylase deficiency). Use of new protein mapping and immunological techniques

Annals of human genetics, 1981-05, Vol.45 (2), p.113-120

1981

Volltextzugriff (PDF)

Outcome of High-Risk Myelodysplastic Syndrome After Azacitidine Treatment Failure

Journal of clinical oncology, 2011-08, Vol.29 (24), p.3322-3327

2011

Volltextzugriff (PDF)

Impact of TET2 mutations on response rate to azacitidine in myelodysplastic syndromes and low blast count acute myeloid leukemias

Leukemia, 2011-07, Vol.25 (7), p.1147-1152

2011

Volltextzugriff (PDF)

Amyloid imaging and CSF biomarkers in predicting cognitive impairment up to 7.5 years later

Neurology, 2013-05, Vol.80 (19), p.1784

2013

Volltextzugriff (PDF)

Autocrine IGF-1/IGF-1R signaling is responsible for constitutive PI3K/Akt activation in acute myeloid leukemia: therapeutic value of neutralizing anti-IGF-1R antibody

Haematologica (Roma), 2010-03, Vol.95 (3), p.415-423

2010

Volltextzugriff (PDF)

TET2 gene mutation is a frequent and adverse event in chronic myelomonocytic leukemia

Haematologica (Roma), 2009-12, Vol.94 (12), p.1676-1681

2009

Volltextzugriff (PDF)

Mutations of IDH1 and IDH2 genes in early and accelerated phases of myelodysplastic syndromes and MDS/myeloproliferative neoplasms

Leukemia, 2010-05, Vol.24 (5), p.1094-1096

2010

Volltextzugriff (PDF)

High-Dose Therapy and Autologous Blood Stem-Cell Transplantation Compared With Conventional Treatment in Myeloma Patients Aged 55 to 65 Years: Long-Term Results of a Randomized Control Trial From the Group Myelome-Autogreffe

Journal of clinical oncology, 2005-12, Vol.23 (36), p.9227-9233

2005

Volltextzugriff (PDF)

TET2 mutations in secondary acute myeloid leukemias: a French retrospective study

Haematologica (Roma), 2011-07, Vol.96 (7), p.1059-1063

2011

Volltextzugriff (PDF)

Comparison of radial forearm flap and thoracodorsal artery perforator flap donor site morbidity for reconstruction of oral and oropharyngeal defects in head and neck cancer

European annals of otorhinolaryngology, head and neck diseases, 2015-09, Vol.132 (4), p.185-189

2015

Volltextzugriff (PDF)

Addition of Androgens Improves Survival in Elderly Patients With Acute Myeloid Leukemia: A GOELAMS Study

Journal of clinical oncology, 2017-02, Vol.35 (4), p.387-393

2017

Volltextzugriff (PDF)

A G polymorphism in the CRBN gene acts as a biomarker of response to treatment with lenalidomide in low/int-1 risk MDS without del(5q)

Leukemia, 2013-07, Vol.27 (7), p.1610-1613

2013

Volltextzugriff (PDF)

Feasibility of percutaneous mitral commissurotomy in patients with commissural mitral valve calcification

European heart journal, 2014-06, Vol.35 (24), p.1617-1623

2014

Volltextzugriff (PDF)

Improved Prognosis of Septic Shock in Patients With Cirrhosis: A Multicenter Study

Critical care medicine, 2014-07, Vol.42 (7), p.1666-1675

2014

Volltextzugriff (PDF)

Right spatial neglect after left hemisphere stroke: qualitative and quantitative study

Neurology, 2004-11, Vol.63 (9), p.1600

2004

Volltextzugriff (PDF)

Impact of case volume on survival of septic shock in patients with malignancies

Critical care medicine, 2012, Vol.40 (1), p.55-62

2012

Volltextzugriff (PDF)

Ofatumumab retreatment and maintenance in fludarabine‐refractory chronic lymphocytic leukaemia patients

British journal of haematology, 2015-07, Vol.170 (1), p.40-49

2015

Volltextzugriff (PDF)

Randomized comparison of fludarabine, CAP, and ChOP in 938 previously untreated stage B and C chronic lymphocytic leukemia patients

Blood, 2001-10, Vol.98 (8), p.2319-2325

2001

Volltextzugriff (PDF)

High‐dose darbepoetin alpha in the treatment of anaemia of lower risk myelodysplastic syndrome results of a phase II study

British journal of haematology, 2006-06, Vol.133 (5), p.513-519

2006

Volltextzugriff (PDF)

Tricuspid regurgitation: Frequency, clinical presentation, management and outcome among patients with severe left‐sided valvular heart disease in Europe. Insights from the ESC‐EORP Valvular Heart Disease II survey

European journal of heart failure, 2024-04, Vol.26 (4), p.994-1003

2024

Volltextzugriff (PDF)

Maintenance therapy with alternating azacitidine and lenalidomide in elderly fit patients with poor prognosis acute myeloid leukemia: a phase II multicentre FILO trial

Blood cancer journal (New York), 2017-06, Vol.7 (6), p.e568-e568

2017

Volltextzugriff (PDF)

Fludarabine plus cyclophosphamide in Waldenström's macroglobulinemia: results in 49 patients

Leukemia, 2005-10, Vol.19 (10), p.1831-1834

2005

Volltextzugriff (PDF)

Hand-rubbing with an aqueous alcoholic solution vs traditional surgical hand-scrubbing and 30-day surgical site infection rates: a randomized equivalence study

JAMA : the journal of the American Medical Association, 2002-08, Vol.288 (6), p.722

2002

Volltextzugriff (PDF)

A non‐randomised dose‐escalating phase II study of thalidomide for the treatment of patients with low‐risk myelodysplastic syndromes: the Thal‐SMD‐2000 trial of the Groupe Français des Myélodysplasies

British journal of haematology, 2005-12, Vol.131 (5), p.609-618

2005

Volltextzugriff (PDF)

1 – 25 von 86

Suche als RSS-Feed

Aktive Filter

ThemaAdult

ThemaHumans

ThemaMiddle Aged

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(59)
Mit Volltextzugriff
(40)

Publikationsform

Artikel
(86)

Sprache

Erscheinungsjahr

n.n

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Research on molecular mechanisms of McArdle's disease (muscle glycogen phosphorylase deficiency). Use of new protein mapping and immunological techniques

Outcome of High-Risk Myelodysplastic Syndrome After Azacitidine Treatment Failure

Impact of TET2 mutations on response rate to azacitidine in myelodysplastic syndromes and low blast count acute myeloid leukemias

Amyloid imaging and CSF biomarkers in predicting cognitive impairment up to 7.5 years later

Autocrine IGF-1/IGF-1R signaling is responsible for constitutive PI3K/Akt activation in acute myeloid leukemia: therapeutic value of neutralizing anti-IGF-1R antibody

TET2 gene mutation is a frequent and adverse event in chronic myelomonocytic leukemia

Mutations of IDH1 and IDH2 genes in early and accelerated phases of myelodysplastic syndromes and MDS/myeloproliferative neoplasms

Lenalidomide with or without erythropoietin in transfusion-dependent erythropoiesis-stimulating agent-refractory lower-risk MDS without 5q deletion

High-Dose Therapy and Autologous Blood Stem-Cell Transplantation Compared With Conventional Treatment in Myeloma Patients Aged 55 to 65 Years: Long-Term Results of a Randomized Control Trial From the Group Myelome-Autogreffe

TET2 mutations in secondary acute myeloid leukemias: a French retrospective study

Comparison of radial forearm flap and thoracodorsal artery perforator flap donor site morbidity for reconstruction of oral and oropharyngeal defects in head and neck cancer

Addition of Androgens Improves Survival in Elderly Patients With Acute Myeloid Leukemia: A GOELAMS Study

A G polymorphism in the CRBN gene acts as a biomarker of response to treatment with lenalidomide in low/int-1 risk MDS without del(5q)

Feasibility of percutaneous mitral commissurotomy in patients with commissural mitral valve calcification

Improved Prognosis of Septic Shock in Patients With Cirrhosis: A Multicenter Study

Right spatial neglect after left hemisphere stroke: qualitative and quantitative study

Impact of case volume on survival of septic shock in patients with malignancies

Ofatumumab retreatment and maintenance in fludarabine‐refractory chronic lymphocytic leukaemia patients

Randomized comparison of fludarabine, CAP, and ChOP in 938 previously untreated stage B and C chronic lymphocytic leukemia patients

High‐dose darbepoetin alpha in the treatment of anaemia of lower risk myelodysplastic syndrome results of a phase II study

Tricuspid regurgitation: Frequency, clinical presentation, management and outcome among patients with severe left‐sided valvular heart disease in Europe. Insights from the ESC‐EORP Valvular Heart Disease II survey

Maintenance therapy with alternating azacitidine and lenalidomide in elderly fit patients with poor prognosis acute myeloid leukemia: a phase II multicentre FILO trial

Fludarabine plus cyclophosphamide in Waldenström's macroglobulinemia: results in 49 patients

Hand-rubbing with an aqueous alcoholic solution vs traditional surgical hand-scrubbing and 30-day surgical site infection rates: a randomized equivalence study

A non‐randomised dose‐escalating phase II study of thalidomide for the treatment of patients with low‐risk myelodysplastic syndromes: the Thal‐SMD‐2000 trial of the Groupe Français des Myélodysplasies

Aktive Filter

Suchergebnisse filtern